Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar S Patel

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Blood Advances|February 24, 2023
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysisBrittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Leukemia|March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationAyman Saad, Lawrence Lamb, Tao Wang, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Blood Advances|February 24, 2023
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysisBrittany Knick Ragon, Mithun Vinod Shah, Anita D'Souza, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Leukemia|October 31, 2022
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Leukemia|March 23, 2023
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patientsMichael Boyiadzis, Mei-Jie Zhang, Karen Chen, et al.
Transplantation and Cellular Therapy|January 26, 2022
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant ResearchHemant S Murthy, Kwang Woo Ahn, Noel Estrada-Merly, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell TransplantationAyman Saad, Lawrence Lamb, Tao Wang, et al.
Pageof 5